Detail of > 150-90-3
- MSDS Download

- CAS Number:
- 150-90-3
- Name:
Butanedioic acid,sodium salt (1:2)
- Superlist Name:
- Disodium succinate
- Formula:
- C4H4Na2O4
- Molecular Structure:

- Synonyms:
- Butanedioicacid, disodium salt (9CI);Succinic acid, disodium salt (8CI);Disodiumsuccinate;SS 50;Sodium succinate;Soduxin;
- Molecular Weight:
- 162.05
- EINECS:
- 205-778-7
- Boiling Point:
- 236.1 °C at 760 mmHg
- Flash Point:
- 110.9 °C
- Solubility:
- water: 300 g/L (25 °C)
Details - particular:
- particular
Related products
- 150-90-3Butanedioic acid,sodium salt (1:2)
- 6106-21-4Butanedioic acid,sodium salt, hydrate (1:2:6)
- 2922-54-5Butanedioic acid,sodium salt (1:1)
- 5799-70-2Methanedisulfonic acid,sodium salt (1:2)
- 141-95-7Propanedioic acid,sodium salt (1:2)
- 17265-14-4Decanedioic acid,sodium salt (1:2)
- 33430-62-55'-Thymidylic acid,sodium salt (1:2)
- 3313-92-6Peroxydicarbonic acid,sodium salt (1:2)
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 10034-88-5Sulfuric acid, sodiumsalt, hydrate (1:1:1)
- 103129-82-4Levamlodipine besylate
- 1984-06-1Octanoic acid, sodiumsalt (1:1)
- 5968-11-6Carbonic acid sodiumsalt (1:2), hydrate (1:1)
- 6151-30-01,4-Pentanediamine,N4-(6-chloro-2-methoxy-9-acridinyl)-N1,N1-diethyl-, hydrochloride, hydrate(1:2:2)
- 5192-23-44-Aminoindole
- 5318-27-46-Aminoindole
- 10124-43-3Sulfuric acid,cobalt(2+) salt (1:1)
- 10034-96-5Manganese, monosulfate, monohydrate
- 35320-67-31H-Indol-4-ol,2-methyl-
- 7558-79-4Disodium hydrogenorthophosphate
- 16730-20-41H-Indole-2-carboxylicacid, 5-nitro-
- 101861-63-61H-Indole-2-carboxylicacid, 4,6-dichloro-
- 10028-24-7Phosphoric acid,disodium salt, dihydrate (8CI,9CI)
- 150-90-3Butanedioic acid,sodium salt (1:2)
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(17)
United States(2)
Germany(1)
India(1)
Japan(1)
- Business Type:
- Importer/Exporter(16)Manufacturers(2)
- Certificates:
- ISO(2)Production License(2)
- Total:22 Page 1 of 1 1
Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required FieldsReference
- Prevention of lysosome disruption in anoxic myocardium by chloroquine and methyl prednisolone
- Prevention of lysosome disruption in anoxic myocardium by chloroquine and methyl prednisolone. Welman, Elizabeth; Peters, T. J. (Dep. Med., R. Postgrad. Med. Sch., London, Engl.). Pharmacol. Res. Commun., 9(1), 29-38 (English) 1977. CODEN: PLRCAT. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) Section cross-reference(s): 2 Isolated guinea pig hearts were perfused anoxically with various concns. 2375-03-3 and 50-63-5 which are cas registry numbers of chemicals are mentioned. of chloroquine diphosphate (I diphosphate) [50-63-5], methyl prednisolone Na succinate (II succinate) [2375-03-3] or Na succinate [150-90-3] alone. The left ventricle tissue was fractionated and the integrity of the myocardial lysosomes was estimated by measurements of latent acid hydrolase activity. Both drugs reduced the damage to lysosomes resulting from anoxic perfusion. The optimal concn. of I was 10-7 M, while II stabilized the lysosomes at 10-5-10-4M. Na succinate alone had a partial lysosome stabilizing action. .
- Interactions between hyperbaric oxygen and drugs
- Interactions between hyperbaric oxygen and drugs. Beubler, E.; Lembeck, F.; Stolze, A. (Inst. Exp. Klin. Pharmakol., Univ. Graz, Graz, Austria). Wien. Klin. Wochenschr., 89(8), 260-5 (German) 1977. CODEN: WKWOAO. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) The lethal effect of O under high pressure (OHP) was diminished by phenobarbitone [50-06-6], propranolol [525-66-6], clonidine [4205-91-8], Na succinate [150-90-3], and tris buffer. The lethal effect of OHP was enhanced by methamphetamine [537-46-2], acetazolamide [59-66-5] and guanethidine [55-65-2]. The lethal effect of OHP was enhanced by reserpine [50-55-5] 2 h after administration, but diminished 12 h after administration. The convulsion threshold of pentetrazol [54-95-5] was decreased under OHP by 26%. The duration of the hypnotic effect of hexobarbitone [56-29-1] was decreased under OHP by 27%. The analgesic effect of morphine [57-27-2] was unchanged by OHP. Practical aspects with regard to the use of drugs during clin. use of OHP are discussed.
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

